Jimenez Freddy A. sold CLDX

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0001838114-25-000007

Machine-readable

Structured copy

Timestamps

Event (reported)

Dec 4, 2025

Published

Dec 8, 2025

Ingested by INSIDER

Nov 5, 04:29 UTC

Last re-read

Nov 5, 04:29 UTC

Extracted facts

Filer

Jimenez Freddy A.

Role

SVP & GENERAL COUNSEL

Transaction

Open-market saleAs filed: “S”

Asset

Celldex Therapeutics, Inc.

Ticker

CLDX

Shares

4,166

Price per share

$29.1

Value

$121,210

Execution date (reported)

Dec 4, 2025

Owned after transaction

30.8K shares

Days from execution to publication

4

Calculation

What this establishes

Jimenez Freddy A. filed this Form 4 reporting a open-market sale of CLDX on Dec 4, 2025. It became public on Dec 8, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

SVP & GENERAL COUNSEL

Jimenez Freddy A.cik:0001838114

Issuer

Celldex Therapeutics, Inc.cik:0000744218

Revision history · 0

No field has changed since this record was first ingested.